全文获取类型
收费全文 | 189716篇 |
免费 | 19812篇 |
国内免费 | 13419篇 |
专业分类
耳鼻咽喉 | 1472篇 |
儿科学 | 2406篇 |
妇产科学 | 1976篇 |
基础医学 | 19261篇 |
口腔科学 | 3711篇 |
临床医学 | 26186篇 |
内科学 | 24508篇 |
皮肤病学 | 2212篇 |
神经病学 | 7998篇 |
特种医学 | 6673篇 |
外国民族医学 | 91篇 |
外科学 | 16106篇 |
综合类 | 39591篇 |
现状与发展 | 55篇 |
一般理论 | 13篇 |
预防医学 | 16282篇 |
眼科学 | 5313篇 |
药学 | 21704篇 |
267篇 | |
中国医学 | 13912篇 |
肿瘤学 | 13210篇 |
出版年
2024年 | 505篇 |
2023年 | 2866篇 |
2022年 | 5611篇 |
2021年 | 9504篇 |
2020年 | 7643篇 |
2019年 | 5938篇 |
2018年 | 6076篇 |
2017年 | 6403篇 |
2016年 | 5564篇 |
2015年 | 9020篇 |
2014年 | 11141篇 |
2013年 | 10862篇 |
2012年 | 16443篇 |
2011年 | 17501篇 |
2010年 | 12595篇 |
2009年 | 10299篇 |
2008年 | 11977篇 |
2007年 | 11543篇 |
2006年 | 10482篇 |
2005年 | 9603篇 |
2004年 | 6377篇 |
2003年 | 5980篇 |
2002年 | 4881篇 |
2001年 | 3953篇 |
2000年 | 3565篇 |
1999年 | 3252篇 |
1998年 | 1926篇 |
1997年 | 1922篇 |
1996年 | 1421篇 |
1995年 | 1267篇 |
1994年 | 1214篇 |
1993年 | 726篇 |
1992年 | 875篇 |
1991年 | 727篇 |
1990年 | 648篇 |
1989年 | 529篇 |
1988年 | 514篇 |
1987年 | 418篇 |
1986年 | 318篇 |
1985年 | 266篇 |
1984年 | 139篇 |
1983年 | 96篇 |
1982年 | 59篇 |
1981年 | 51篇 |
1980年 | 26篇 |
1979年 | 56篇 |
1978年 | 17篇 |
1977年 | 15篇 |
1975年 | 11篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
目的探讨用3M无痛保护膜联合造口袋治疗大便失禁相关性皮炎(Incontinent dermatitis,IAD)的疗效。方法选择我院2014年12月至2015年6月收治的50例IAD患者为研究对象,按照随机数表法将其分为对照组与实验组,每组25例。对照组患者予以传统皮肤护理方法;实验组的患者除传统皮肤护理外加用3M无痛保护膜联合造口袋治疗。并比较两组患者治疗后的皮炎改善情况、皮炎愈合时间及皮炎复发率。结果实验组患者治疗效果明显优于对照组,实验组皮炎愈合短于对照组,实验组皮炎复发率明显低于对照组,差异均有统计学意义(P<0.05)。结论 3M无痛保护膜联合造口袋治疗IAD,临床效果显著,且愈合快,复发低。 相似文献
62.
63.
目的 利用筛选出十堰的天师栗中高多态性SSR位点评价天师栗种质资源的遗传多样性,结合有效药用成分含量,构建十堰地区天师栗核心种质库。方法 收集十堰地区114份天师栗种质资源,以七叶树基因组为参考,采用荧光毛细管电泳筛选出高多态性SSR位点,对天师栗种质资源进行遗传多样性分析。利用HPLC测定不同种质干燥娑罗子中七叶皂苷的含量。采用最小距离逐步聚类取样策略(LDSS),根据遗传多样性保留程度初步筛选出核心种质,并对该核心种质与原始种质的遗传多样性参数进行T检验,选择与原种质差异不显著的核心种质为最佳核心种质。结果 筛选出13对高多态性SSR分子标记,遗传多样性评价结果表明十堰地区天师栗种质资源遗传多样性较高,遗传分化较小,存在着较大的基因流,114份种质资源未分为不同的亚群,周家坝和辽叶居群间具有较近的遗传亲缘关系,且周家坝居群娑罗子中的七叶皂苷A及七叶皂苷B含量普遍较高。最终筛选出的核心种质共23份,占总种质资源的20.17%,其中周家坝12份样本、辽叶6份样本、普龄5份样本。结论 将SSR分子标记与主要有效药用成分结合,采用LDSS取样策略构建十堰地区天师栗种质资源核心种质库的方法具有可行性,能够有效的保存与管理天师栗种质资源,也为当地天师栗品种改良、新品种选育研究等提供了研究基础。 相似文献
64.
Kensuke Kudou Hiroshi Saeki Yuichiro Nakashima Shun Sasaki Tomoko Jogo Kosuke Hirose Qingjiang Hu Yasuo Tsuda Koichi Kimura Ryota Nakanishi Nobuhide Kubo Koji Ando Eiji Oki Tetsuo Ikeda Yoshihiko Maehara 《American journal of surgery》2019,217(4):757-763
Background
There were few studies assessed the postoperative sarcopenia in patients with cancers. The objective of present study was to assess whether postoperative development of sarcopenia could predict a poor prognosis in patients with adenocarcinoma of esophagogastric junction, (AEG) and upper gastric cancer (UGC).Methods
Patients with AEG and UGC who were judged as non-sarcopenic before surgery were reassessed the presence of postoperative development of sarcopenia 6 months after surgery. Patients were divided into the development group or non-development group, and clinicopathological factors and prognosis between these two groups were analyzed.Results
The 5-year overall survival rates were significantly poorer in the development group than non-development group (68.0% vs. 92.6%, P?=?0.0118). Multivariate analyses showed that postoperative development of sarcopenia was an independent prognostic factor for poor overall survival (P?=?0.0237).Conclusions
Postoperative development of sarcopenia was associated with a poor prognosis in patients with AEG and UGC. 相似文献65.
Wan-Hua Cui Ze-Zhi Li Yan Guo Mei-Ling Gao Yong-Xian Cheng 《Journal of Asian natural products research》2019,21(1):1-8
Four new diarylheptanoids, (1S, 3R, 5R, 6R)-1, 5-epoxy-3, 6 dihydroxy-1-(4-hydroxy-3, 5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl) heptane (1), (1R, 3R, 5S)-1, 5-epoxy-3-acetoxy-1-(4, 5-dihydroxy-3-methoxyphenyl)-7-(3, 4- hydroxyphenyl) heptane (2), (3R, 5S, 6R, 7S)-3, 6-epoxy-7-hydroxyl-1-(4-hydroxyphenyl)-7-(3-methoxy-4-hydroxyphenyl) heptane (3), (E)-3-keto-1-(3-methoxy-4-hydroxyphenyl)-7-(4, 5-dihydroxy-3-methoxyphenyl)-4- heptene (4), were isolated from Rhizoma Zingiberis, and their structures were determined based on HR-ESI-MS and extensive spectroscopic techniques (UV, IR, 1D-NMR and 2D-NMR). Compounds 1–4 exhibited no cytotoxicity against HepG2 cell lines.
66.
M.‐Q. Man L. Ye L. Hu S. Jeong P. M. Elias C. Lv 《Clinical and experimental dermatology》2019,44(6):654-657
While therapeutic approaches for psoriasis are widely available, preventive regimens are lacking. We aimed to determine whether improvements in epidermal function could prevent psoriasis relapse. Two self‐controlled cohort studies were designed, enrolling two cohorts of patients with psoriasis (n = 30 and n = 60) to be treated topically with an in‐house‐prepared emollient or ATOPALM® cream applied twice daily to one forearm for 20 and 30 days, respectively, while the same sites on the contralateral arm served as the untreated control. Epidermal function on both arms was assessed prior to and at the end of the trials. Delayed relapse on the treated arm was seen in 54.5% and 71% of patients in the first and second cohort, respectively. The time of psoriatic relapse correlated with the extent of abnormalities in baseline epidermal function. These results suggest that improvements in epidermal function with topical emollients can prevent/attenuate the development of psoriasis. 相似文献
67.
68.
Ju Zou Daichao Wu Tao Li Xianwen Wang Yan Liu Sijie Tan 《Pathology, research and practice》2019,215(2):229-234
Programmed death ligand 1(PD-L1) mediated immune escape play important roles in the development of cancer. The gene polymorphism of PD-L1, in particular rs4143815 C?>?G, has been associated with the cancer risks, but with conflicting results. Therefore, this meta-analysis was aimed to assess the association between rs4143815 C?>?G and cancer susceptibility. A systematic literature search was performed to select the studies and the pooled odds ratio (OR) with 95% confidence interval (CI) was used to evaluate the strength of association. Eleven eligible studies containing 3711 cases and 3704 controls were enrolled in the meta-analysis. The results suggested that there is a strong association between rs4143815 C?>?G and the cancer risks (G vs. C: OR?=?1.386, 95% CI: 1.132–1.696, p?=?0.002; GG vs. CG?+?CC: OR?=?1.843 95% CI: 1.300–2.613, p?=?0.002; GG?+?CG vs. CC: OR?=?1.280, 95% CI: 1.040–1.576, p?=?0.020). Subgroup analysis based on cancer type suggested that PD-L1 rs4143815 C?>?G might increase the susceptibility to gastric cancer (G vs. C: OR?=?1.842, 95% CI: 1.403–2.418, p?<?0.001) and bladder cancer (G vs. C: OR?=?2.015, 95% CI: 1.556–2.608, p?<?0.001), and genotype GG carriers of PD-L1 rs4143815 C?>?G might have higher risks of HCC (GG vs. CG?+?CC: OR?=?2.226 95% CI: 1.562–3.172, p?<?0.001). PD-L1 rs4143815 C?>?G might confer an increased cancer risk, indicating this SNP may contribute to the pathogenesis of cancer and might be used as a potential biomarker to predict the susceptibility to cancer. 相似文献
69.
70.